-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

Benzinga·10/06/2026 10:07:56
Listen to the news
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.